Community Health Systems Announces That Lynn Simon, MD, President, Healthcare Innovation and Chief Medical Officer, Will Retire and Transition Into a Consulting Role at the End of the Year
Simon joined
Among her many accomplishments at CHS, Simon established one of the first AHRQ-certified Patient Safety Organizations (PSO) along with the framework, expectations, and tools that helped achieve a 90% reduction in the serious safety event rate over the past decade. Simon developed CHS’ proprietary Transfer Center, creating round the clock access to help hospitals inside and outside of the CHS organization facilitate prompt and safe patient transfers between facilities ensuring patients quickly receive the services and level of care needed. Simon also led the development of the CHS Patient Access Center, which provides centralized scheduling for patient appointments into primary care practices. The Transfer Center and Patient Access Center have been key to creating better access to health services and driving growth at CHS-affiliated health systems.
In early 2023, Simon assumed a new executive leadership role designed to accelerate innovation across CHS. Simon has forged relationships and implemented technologies that are improving care delivery, creating better patient experiences, streamlining workflows, and improving the work experience for clinicians and support teams. Some of these advancements include implementation of a remote patient monitoring program for people with chronic conditions that currently serves more than 14,000 people, a virtual patient sitting program that is designed to provide 24/7 monitoring to help protect hospitalized patients at high risk for falls, a maternal-fetal early warning system that uses AI to improve safety in childbirth, and a partnership with Mark Cuban Cost Plus Drugs that is addressing drug shortages and the rising costs of pharmaceuticals used in hospital settings.
Commenting on today’s announcement
As part of a long-term succession plan,
Hingtgen said, “Miguel is an extremely accomplished clinical and operational leader who is highly regarded by physicians, nurses, health system administrators, and his colleagues at CHS. He is a solutions-oriented leader whose unique perspectives already are advancing clinical care in our health systems. CHS will continue to benefit from Miguel’s expertise and commitment to the future of medicine as he assumes the role of President of Clinical Operations and Chief Medical Officer next year.”
In addition to her consulting role at CHS, Simon plans to remain involved in the healthcare industry with a continuing focus on innovation. Simon has cultivated relationships with venture capital firms, start-up companies, and others who are creating new solutions for healthcare. In addition, she looks forward to focusing on current and potential future board and advisory opportunities. Simon serves on the board of directors for Ascend Learning, ForeFront Dermatology, and Cadence. Simon has received numerous awards and recognitions, including being named to Modern Healthcare’s lists of the Top Healthcare Innovators, 50 Most Influential Physician Executives and Leaders, and the Top 25 Women in Healthcare.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20240911869685/en/
Media Contact:
Executive Vice President – Corporate Communications and Marketing
615-628-6607
Investor Contacts:
President and Chief Financial Officer
615-465-7000
or
Anton Hie
Vice President – Investor Relations
615-465-7012
Source: